Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 3,600 KRW
Change Today -285.00 / -7.34%
Volume 135.8K
109820 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:18 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

genematrix inc (109820) Snapshot

Open
3,940
Previous Close
3,885
Day High
3,940
Day Low
3,555
52 Week High
07/7/15 - 4,950
52 Week Low
12/16/14 - 2,385
Market Cap
30.5B
Average Volume 10 Days
119.8K
EPS TTM
-135.00
Shares Outstanding
8.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GENEMATRIX INC (109820)

Related News

No related news articles were found.

genematrix inc (109820) Related Businessweek News

No Related Businessweek News Found

genematrix inc (109820) Details

GeneMatrix Inc. develops platform and molecular diagnostics products. It offers products for hepatology, sexually transmitted diseases, genetic diseases, pharmacogenetics, HIV/AIDS, respiratory-flu, and natural medicines, as well as products for the detection of HBV drug resistance, genotyping diagnostics of cervical cancer, prognosis and the early diagnosis of hepatocellular carcinoma, and detection of anti-cancer resistance. The company operates in the areas of mass spectrometry-based diagnostic system, molecular diagnostics and theranostics, cancer risk prediction diagnostics, organic agriculture testing, and new medicine development. GeneMatrix Inc. was founded in 2000 and is headquartered in Seongnam, South Korea.

Founded in 2000

genematrix inc (109820) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genematrix inc (109820) Key Developments

GeneMatrix Inc., Annual General Meeting, Mar 27, 2015

GeneMatrix Inc., Annual General Meeting, Mar 27, 2015., at 09:00 Korea Standard Time. Location: Sampyeong-dong Bundang-gu. Agenda: To consider the approval of financial statement; to consider the election of director; to consider the approval of director remuneration; to consider the approval of the remuneration; to consider other references concerning investment decisions; and to consider and approve other business.

GeneMatrix Inc., Annual General Meeting, Mar 28, 2014

GeneMatrix Inc., Annual General Meeting, Mar 28, 2014., at 11:00 Korea Standard Time. Location: Korea Bio Park B- 700 auditorium. Agenda: To consider the approval of financial statement; to consider the election of Director; to consider the approval of director remuneration; to consider the approval of the remuneration; and to consider other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
109820:KS 3,600.00 KRW -285.00

109820 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 109820.
View Industry Companies
 

Industry Analysis

109820

Industry Average

Valuation 109820 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.8x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENEMATRIX INC, please visit www.genematrix.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.